Endometrial Cancer Human Endometrium Tissue Genomic DNA, Donor 919 (CAT#: DBFF-0624-HY2371)

Datasheet

Overview

Endometrial cancer is a malignant tumor that occurs in the lining of the uterus and is mainly caused by excessive proliferation of endometrial cells. It is a relatively common gynecological cancer that usually occurs in postmenopausal women. Endometrial Cancer Human Endometrium Tissue Genomic DNA, Donor 919 is a highly pure intact high molecular size DNA. It is extracted from endometrium tissue of endometrial cancer human donor and treated with DNase-free RNase to remove contaminant RNA. Its purity and intactness make it an ideal choice for researchers seeking reliable and accurate data in their genetic research.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Female

Age At Sampling

64 yrs

Medical Diagnosis

Carcinosarcoma of endometrium

Product Description

Species

Human

Tissue Name

Endometrium

Sample Diagnosis Category

Endometrial Cancer

28S/18S Ratio

2.00

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Southern blot analysis, polymerase chain reaction amplification, genomic DNA methylation, single nucleotide polymorphism analysis, profiling studies in gene expression, and DNA library construction.

Product Properties

Metastatic Site

Uterus

Normal Ratio

Lesional Ratio

Tumor Ratio

85%

Hypocellular/Acellular Tumor Stroma Ratio

Hypercellular Tumor Stroma Ratio

15%

Necrosis Ratio

Histopathological Grade

AJCC G4: Undifferentiated

Tumor Stage

IIIC

Primary Tumor (T)

T2b

Regional Lymph Node (N)

Distant Metastasis (M)

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use